FDA Warning Letter — AQ USA, Inc.

Case 719517 — FEI 3015167023

The FDA took a Warning Letter action against AQ USA, Inc. on Feb 12, 2026 (Lynden, WA). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
AQ USA, Inc.
Date
Feb 12, 2026
Fiscal Year
2026
Product Type
Drugs
Center
CDER
Location
Lynden, WA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.